MX388028B - Suministro de antioxidantes bioactivos, nanoencapsulados. - Google Patents
Suministro de antioxidantes bioactivos, nanoencapsulados.Info
- Publication number
- MX388028B MX388028B MX2017001903A MX2017001903A MX388028B MX 388028 B MX388028 B MX 388028B MX 2017001903 A MX2017001903 A MX 2017001903A MX 2017001903 A MX2017001903 A MX 2017001903A MX 388028 B MX388028 B MX 388028B
- Authority
- MX
- Mexico
- Prior art keywords
- antioxidant
- nanoparticles
- bioactive
- compositions
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5169—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5192—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462035683P | 2014-08-11 | 2014-08-11 | |
| US201562172455P | 2015-06-08 | 2015-06-08 | |
| PCT/US2015/044483 WO2016025394A2 (en) | 2014-08-11 | 2015-08-10 | Delivery of bioactive, nanoencapsulated antioxidants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017001903A MX2017001903A (es) | 2017-09-26 |
| MX388028B true MX388028B (es) | 2025-03-19 |
Family
ID=55304745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017001903A MX388028B (es) | 2014-08-11 | 2015-08-10 | Suministro de antioxidantes bioactivos, nanoencapsulados. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10292943B2 (enExample) |
| EP (1) | EP3179988A4 (enExample) |
| JP (1) | JP6668327B2 (enExample) |
| KR (1) | KR102218883B1 (enExample) |
| AP (1) | AP2017009684A0 (enExample) |
| AU (1) | AU2015301945B2 (enExample) |
| BR (1) | BR112017002580A2 (enExample) |
| CA (1) | CA2992879C (enExample) |
| EA (1) | EA035620B1 (enExample) |
| MX (1) | MX388028B (enExample) |
| WO (1) | WO2016025394A2 (enExample) |
| ZA (1) | ZA201700987B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP2017009684A0 (enExample) * | 2014-08-11 | 2017-01-31 | ||
| WO2019148140A2 (en) * | 2018-01-26 | 2019-08-01 | Wu Joseph C | Implantable biomaterials that enhance stem cell survival and function |
| WO2020249825A1 (en) * | 2019-06-14 | 2020-12-17 | Folium Biosciences Europe B.V. | Method for micro-encapsulation of natural ingredients by means of contacting with supercritical gas |
| IL297592A (en) * | 2020-05-11 | 2022-12-01 | Op2Lysis | A slow release formulation of a plasmogen activator for use in the treatment of thrombosis or hemorrhagic disease |
| US11298321B1 (en) | 2021-07-12 | 2022-04-12 | King Abdulaziz University | Methods for treating metabolic disorder |
| US11253481B1 (en) | 2021-07-12 | 2022-02-22 | King Abdulaziz University | Self-nanoemulsifying 3D-printed tablet composition and method of use thereof |
| KR102824097B1 (ko) | 2022-12-07 | 2025-06-24 | 주식회사 엘지생활건강 | 바이오틴이 담지된 나노파티클 및 이의 제조 방법, 및 이의 용도 |
| WO2025106389A1 (en) * | 2023-11-13 | 2025-05-22 | Universitatea De Medicină Şi Farmacie Iluiu Haţieganu | New forms of lutein and their uses |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0386960A3 (en) | 1989-03-07 | 1991-10-23 | American Cyanamid Company | Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings |
| US6573299B1 (en) * | 1999-09-20 | 2003-06-03 | Advanced Medical Instruments | Method and compositions for treatment of the aging eye |
| US6703039B2 (en) * | 2000-12-06 | 2004-03-09 | Bausch & Lomb Incorporated | Reversible gelling system for ocular drug delivery |
| DE10141018A1 (de) * | 2001-08-22 | 2003-03-13 | Eth Zuerich Eidgenoessische Te | Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges |
| US20040009212A1 (en) | 2002-01-30 | 2004-01-15 | Pharma Power Biotec Co. Ltd. | Mucoadhesive thermoresponsive medicament-carrier composition |
| ATE424795T1 (de) | 2002-06-05 | 2009-03-15 | Univ Florida | Ophthalmisches arzneimittelabgabesystem |
| JP2009515821A (ja) * | 2005-10-16 | 2009-04-16 | リコレッド リミテッド | 眼疾患を治療するための組成物 |
| WO2008137831A1 (en) * | 2007-05-07 | 2008-11-13 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Water-soluble nanoparticles containing water-insoluble compounds |
| PT2594140T (pt) | 2010-07-16 | 2019-06-11 | Centro Nac De Tecnologia Y Seguridad Alimentaria Laboratorio Dei Ebro | Nanopartículas para encapsulamento de compostos, sua produção e utilizações |
| MX2013002115A (es) | 2010-09-03 | 2013-06-28 | Novagali Pharma Sa | Una emulsion del tipo de agua en aceite para tratar una enfermedad de los ojos. |
| EP2678007A4 (en) * | 2011-02-25 | 2015-08-12 | Univ South Dakota | PROTEIN NANOTRIER FOR TOPICAL ADMINISTRATION |
| US20120231072A1 (en) * | 2011-03-11 | 2012-09-13 | Chemisches Institut Schaefer Ag | Thermo-responsive hydrogel compositions |
| CN103845278B (zh) * | 2012-11-30 | 2016-06-22 | 沈阳药科大学 | 一种叶黄素眼用纳米乳-温度敏感型原位凝胶及其制备方法 |
| AP2017009684A0 (enExample) * | 2014-08-11 | 2017-01-31 |
-
2015
- 2015-08-10 AP AP2017009684A patent/AP2017009684A0/en unknown
- 2015-08-10 MX MX2017001903A patent/MX388028B/es unknown
- 2015-08-10 WO PCT/US2015/044483 patent/WO2016025394A2/en not_active Ceased
- 2015-08-10 CA CA2992879A patent/CA2992879C/en active Active
- 2015-08-10 JP JP2017505869A patent/JP6668327B2/ja active Active
- 2015-08-10 BR BR112017002580A patent/BR112017002580A2/pt not_active Application Discontinuation
- 2015-08-10 KR KR1020177003119A patent/KR102218883B1/ko active Active
- 2015-08-10 EA EA201790361A patent/EA035620B1/ru unknown
- 2015-08-10 AU AU2015301945A patent/AU2015301945B2/en active Active
- 2015-08-10 US US15/502,415 patent/US10292943B2/en active Active
- 2015-08-10 EP EP15831551.5A patent/EP3179988A4/en active Pending
-
2017
- 2017-02-03 ZA ZA2017/00987A patent/ZA201700987B/en unknown
-
2019
- 2019-04-30 US US16/399,388 patent/US10952974B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MX2017001903A (es) | 2017-09-26 |
| AP2017009684A0 (enExample) | 2017-01-31 |
| US20170216221A1 (en) | 2017-08-03 |
| US10952974B2 (en) | 2021-03-23 |
| BR112017002580A2 (pt) | 2018-03-27 |
| AU2015301945A1 (en) | 2017-03-09 |
| KR102218883B1 (ko) | 2021-02-23 |
| JP6668327B2 (ja) | 2020-03-18 |
| ZA201700987B (en) | 2019-05-29 |
| US20190254987A1 (en) | 2019-08-22 |
| WO2016025394A2 (en) | 2016-02-18 |
| EP3179988A2 (en) | 2017-06-21 |
| AU2015301945B2 (en) | 2020-05-14 |
| EA201790361A1 (ru) | 2017-06-30 |
| KR20170097601A (ko) | 2017-08-28 |
| JP2017523983A (ja) | 2017-08-24 |
| WO2016025394A3 (en) | 2016-05-19 |
| EP3179988A4 (en) | 2018-11-14 |
| US10292943B2 (en) | 2019-05-21 |
| CA2992879A1 (en) | 2016-02-18 |
| CA2992879C (en) | 2022-10-25 |
| EA035620B1 (ru) | 2020-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX388028B (es) | Suministro de antioxidantes bioactivos, nanoencapsulados. | |
| HK1243942A1 (zh) | 舒尼替尼制剂及其在治疗青光眼中的使用方法 | |
| HK1218850A1 (zh) | 持续药物递送植入物 | |
| EP4279064A3 (en) | Drug delivery from hydrogels | |
| BR112015006929A2 (pt) | sistemas de distribuição de droga biodegradável para liberação sustentada de proteínas | |
| HK1249140A1 (zh) | 用於调节tmprss6表达的化合物和方法 | |
| HK1252771A1 (zh) | 用於治疗眼部病状的玻璃体内药物递送系统 | |
| PH12017502155A1 (en) | Formation of cyclosporin a/cyclodextrin nanoparticles | |
| WO2011084366A3 (en) | Compositions and drug delivery systems for intraocular delivery of sirna molecules, their use for treating conditions | |
| WO2014143754A3 (en) | Prostamide-containing intraocular implant | |
| MX2016012846A (es) | Preparacion de microesferas de plga cargadas de peptido con caracteristicas de liberacion controlada. | |
| EP3176163A4 (en) | Novel indene derivative, preparation method for same, and pharmaceutical composition, for preventing or treating retinal diseases, containing same as active ingredient | |
| PT3678673T (pt) | Composições e processos para aministração dirigida, expressão e modulação de ácidos robonucleicos codificantes num tecido | |
| MX2022002306A (es) | Metodos de tratamiento de enfermedades oculares con un implante para la administracion sostenida de farmacos. | |
| ZA201701303B (en) | Ocular formulations for drug-delivery and protection of the anterior segment of the eye | |
| EP3167893A4 (en) | Pharmaceutical composition containing spirulina maxima extract as active ingredient for preventing and treating retinal diseases | |
| MX2019003365A (es) | Composiciones de ester de colina de acido lipoico y metodos para estabilizar en productos farmacologicos farmaceuticamente relevantes. | |
| MX2020012011A (es) | Conjugados y derivados de prostaglandina para tratar el glaucoma y la hipertension ocular. | |
| MX385405B (es) | Composición inyectable en el vítreo de un ojo que comprende un inhibidor de cinasa y el uso de la misma para tratar una enfermedad ocular. | |
| MX2016009600A (es) | Agentes para utilizarse en el tratamiento de la inflamacion de retina. | |
| SG11202004940VA (en) | Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye | |
| WO2019022482A3 (ko) | 황칠나무 추출물을 유효성분으로 포함하는 섬유화 질환의 예방 또는 치료용 조성물 | |
| HK1238134A1 (en) | Delivery of bioactive, nanoencapsulated antioxidants | |
| UY33562A (es) | Agonistas de receptores de bradicinina y su utilización para el tratamiento de la hipertensión ocular y el glaucoma | |
| NZ734845A (en) | Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease |